![Gamida Cell Ltd. logo](/logos/GMDA.webp)
Gamida Cell Ltd.
NASDAQ:GMDA
Overview | Financials
Company Name | Gamida Cell Ltd. |
Symbol | GMDA |
Currency | USD |
Price | 0.033 |
Market Cap | 4,337,295 |
Dividend Yield | 0% |
52-week-range | 0.03 - 2.51 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Ms. Abigail L. Jenkins |
Website | https://www.gamida-cell.com |
An error occurred while fetching data.
About Gamida Cell Ltd.
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials in
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD